111 related articles for article (PubMed ID: 7613155)
1. Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist.
Carballido JM; Aversa G; Schols D; Punnonen J; de Vries JE
Int Arch Allergy Immunol; 1995; 107(1-3):304-7. PubMed ID: 7613155
[TBL] [Abstract][Full Text] [Related]
2. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
[TBL] [Abstract][Full Text] [Related]
3. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the human IgE response.
de Vries JE; Yssel H
Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
[TBL] [Abstract][Full Text] [Related]
5. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.
Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A
J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
König B; Fischer A; König W
Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
[TBL] [Abstract][Full Text] [Related]
8. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny.
Punnonen J; Cocks BG; de Vries JE
J Immunol; 1995 Nov; 155(9):4248-54. PubMed ID: 7594582
[TBL] [Abstract][Full Text] [Related]
9. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency.
Tony HP; Shen BJ; Reusch P; Sebald W
Eur J Biochem; 1994 Oct; 225(2):659-65. PubMed ID: 7957181
[TBL] [Abstract][Full Text] [Related]
10. X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain.
Matthews DJ; Hibbert L; Friedrich K; Minty A; Callard RE
Eur J Immunol; 1997 Jan; 27(1):116-21. PubMed ID: 9022007
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
Maeda S; Yanagihara Y
Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
[TBL] [Abstract][Full Text] [Related]
13. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice.
Mayer RJ; Bolognese BJ; Al-Mahdi N; Cook RM; Flamberg PL; Hansbury MJ; Khandekar S; Appelbaum E; Faller A; Marshall LA
Clin Exp Allergy; 2000 May; 30(5):719-27. PubMed ID: 10792365
[TBL] [Abstract][Full Text] [Related]
15. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
[TBL] [Abstract][Full Text] [Related]
16. Recombinant canine IL-13 receptor alpha2-Fc fusion protein inhibits canine allergen-specific-IgE production in vitro by peripheral blood mononuclear cells from allergic dogs.
Tang L; Boroughs KL; Morales T; Stedman K; Sellins K; Clarke K; McDermott M; Yang S; McCall C
Vet Immunol Immunopathol; 2001 Nov; 83(1-2):115-22. PubMed ID: 11604166
[TBL] [Abstract][Full Text] [Related]
17. The role of IL-13 and its receptor in allergy and inflammatory responses.
de Vries JE
J Allergy Clin Immunol; 1998 Aug; 102(2):165-9. PubMed ID: 9723655
[TBL] [Abstract][Full Text] [Related]
18. IL-21 effects on human IgE production in response to IL-4 or IL-13.
Wood N; Bourque K; Donaldson DD; Collins M; Vercelli D; Goldman SJ; Kasaian MT
Cell Immunol; 2004; 231(1-2):133-45. PubMed ID: 15919378
[TBL] [Abstract][Full Text] [Related]
19. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.
Zurawski SM; Vega F; Huyghe B; Zurawski G
EMBO J; 1993 Jul; 12(7):2663-70. PubMed ID: 8101483
[TBL] [Abstract][Full Text] [Related]
20. IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice.
Schols D; Vandekerckhove B; Jones D; Roncarolo MG
J Immunol; 1994 Mar; 152(5):2198-206. PubMed ID: 8133034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
